Latest News About - obstetrical and gynaecological devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Wednesday, October 27, 2021

12:45:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fo
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
ny
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Jared Friedman says: “The idea that a recent PhD or postdoc could actually start their own successful therapeutics company was quite a radical idea at the time; it’s still not widely accepted,” External link

forbes Tuesday, October 26, 2021 3:25:00 PM CEST

Robert W Carlson said: "It's easier to predict cancer care needs when we work together to standardize care on an international scale—carefully adjusted for unique regional variations—improving quality while controlling costs," External link

markets-businessinsider Monday, October 25, 2021 3:28:00 PM CEST

David McNally stated: “We are pleased to report that the studies were completed on time, adding to the cadre of data supporting the Enos system’s use in pre-clinical studies. These studies provide critical input toward the final steps of development in preparation for regulatory submissions. We look forward to finalizing product development of the Enos system and continuing with our plans for application for investigational device exemption with the FDA, and once approved, proceeding with clinical studies,” External link

eagletribune Monday, October 25, 2021 2:06:00 PM CEST

David McNally stated: “We are pleased to report that the studies were completed on time, adding to the cadre of data supporting the Enos system’s use in pre-clinical studies. These studies provide critical input toward the final steps of development in preparation for regulatory submissions. We look forward to finalizing product development of the Enos system and continuing with our plans for application for investigational device exemption with the FDA, and once approved, proceeding with clinical studies,” External link

financialpost Monday, October 25, 2021 1:36:00 PM CEST

Robert W Carlson said: "It's easier to predict cancer care needs when we work together to standardize care on an international scale-carefully adjusted for unique regional variations-improving quality while controlling costs," External link

finanznachrichten-en Monday, October 25, 2021 10:54:00 AM CEST

Kate Brown said: "Constantly moving the research field forward is imperative for improving reproductive health services," External link

prnewswire Thursday, October 21, 2021 2:28:00 PM CEST

César de la Fuente said: "Our dream is to someday maybe see one of these in pharmacies," External link

wkbw Monday, October 18, 2021 8:19:00 PM CEST

César de la Fuente said: "I thought, OK, we're going to need to hire more people to help do all this stuff," "I don’t really have the personnel to take on that now" External link

wkbw Monday, October 18, 2021 8:19:00 PM CEST

Gigi Gronvall said: "For at-home tests, that bar has always been a little bit higher," External link

wkbw Monday, October 18, 2021 8:19:00 PM CEST

Kim Schrier said: "It sure would be nice if we could buy some of those tests, having evaluated them," "We would have this capacity in this tool that so many other countries already have" External link

wkbw Monday, October 18, 2021 8:19:00 PM CEST

César de la Fuente said: "We have to follow the rules; they're in place for a reason," External link

wkbw Monday, October 18, 2021 8:19:00 PM CEST

César de la Fuente said: "I would say the main challenge would be scaling up production," External link

wkbw Monday, October 18, 2021 8:19:00 PM CEST

Robert Kline said: “Becoming part of Hologic and its highly respected and well-known Surgical business is an exciting and pivotal junction for Bolder,” External link

businesswire Friday, October 15, 2021 9:14:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.